Fred D. Lublin, MD

Saunders Family Professor of Neurology, and director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine, Mount Sinai

Articles by Fred D. Lublin, MD

Classification and Diagnosis of SPMS

ByBruce Cree, MD, PhD, MAS, FAAN,Joseph R. Berger, MD,Kristen Krysko, MD,Fred D. Lublin, MD,Robert Fox, MD

March 24th 2021

Fred D. Lublin, MD, leads a discussion about the different classifications of secondary progressive multiple sclerosis, including the relationship between disease activity and progression of disease.

Diagnosing SPMS

ByBruce Cree, MD, PhD, MAS, FAAN,Joseph R. Berger, MD,Kristen Krysko, MD,Fred D. Lublin, MD,Robert Fox, MD

March 18th 2021

An overview of the criteria used to diagnose relapsing-remitting multiple sclerosis when it converts to secondary progressive multiple sclerosis.

Clinical Subtypes of MS

ByBruce Cree, MD, PhD, MAS, FAAN,Joseph R. Berger, MD,Kristen Krysko, MD,Fred D. Lublin, MD,Robert Fox, MD

March 18th 2021

A panel of experts led by Bruce Cree, MD, highlight the clinical subtypes of multiple sclerosis including presentation and prevalence.

Fred D. Lublin, MD

Articles by Fred D. Lublin, MD

Classification and Diagnosis of SPMS

Diagnosing SPMS

Clinical Subtypes of MS

The Future of Treating Multiple Sclerosis

Decision-Making Process for Treating Multiple Sclerosis

Switching Therapies in Multiple Sclerosis

Role of Ozanimod in Multiple Sclerosis

Role of Diroximel Fumarate in Multiple Sclerosis

Role of Ocrelizumab in Europe for Multiple Sclerosis

Ocrelizumab for the Treatment of Multiple Sclerosis

Role of Siponimod in Multiple Sclerosis

Treating With Cladribine in Multiple Sclerosis

Clinical Trials for Cladribine in Multiple Sclerosis

The Use of Glatiramer Acetate in Multiple Sclerosis

The Use of Interferon in Multiple Sclerosis

First-Line Therapies for Relapsing Multiple Sclerosis

Clinically Isolated Syndrome Versus Multiple Sclerosis

MOG-IgG in Multiple Sclerosis

Differential Diagnosis of Multiple Sclerosis

Diagnosis of Multiple Sclerosis: The McDonald Criteria

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential

Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O'Shea, MD, MSc

Ketogenic Diet Shows Significant Effect on Seizure Reduction in Children With Drug-Resistant Epilepsy

Real-World Data Highlight Increased Safety Events of Dopamine D2 Receptor Antagonists in Pediatric Tourette Syndrome

Early Results Show Symptom Gains in First Patient Dosed With UX-DA001 Cell Therapy for Parkinson Disease